Literature DB >> 11899549

Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease.

Sanjay Sethi1.   

Abstract

In patients with Influenza, the risk of death from pneumonia is closely associated with age and chronic conditions. Mortality from influenza and pneumonia in Americans age > or = 65 has been increasing since 1980. Pneumonia following influenza is usually caused by a secondary bacterial infection. Pathogens most commonly implicated are Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae. Prompt empiric therapy effective against the suspected pathogen is indicated, whether the patient is being treated as an outpatient or requires inpatient observation or hospitalization for i.v. administration. Influenza vaccination of older patients living in the community has been shown to decrease hospitalizations for influenza and pneumonia by 52% and mortality by 70% in those with chronic lung disease. Protective rates are similar for residents of long-term care facilities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11899549

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  13 in total

1.  Fatal influenza A infection with Staphylococcus aureus superinfection in a 49-year-old woman presenting as sudden death.

Authors:  M Tsokos; B Zöllner; H-H Feucht
Journal:  Int J Legal Med       Date:  2004-08-19       Impact factor: 2.686

Review 2.  Current knowledge on PB1-F2 of influenza A viruses.

Authors:  Andi Krumbholz; Anja Philipps; Hartmut Oehring; Katja Schwarzer; Annett Eitner; Peter Wutzler; Roland Zell
Journal:  Med Microbiol Immunol       Date:  2010-10-16       Impact factor: 3.402

Review 3.  Epidemiology and management of common pulmonary diseases in older persons.

Authors:  Kathleen M Akgün; Kristina Crothers; Margaret Pisani
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-02-15       Impact factor: 6.053

4.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.

Authors:  Arash Shahangian; Edward K Chow; Xiaoli Tian; Jason R Kang; Amir Ghaffari; Su Y Liu; John A Belperio; Genhong Cheng; Jane C Deng
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

5.  Evidence from multiplex molecular assays for complex multipathogen interactions in acute respiratory infections.

Authors:  John D Brunstein; Christy L Cline; Steven McKinney; Eva Thomas
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

6.  A mouse model of lethal synergism between influenza virus and Haemophilus influenzae.

Authors:  Lian Ni Lee; Peter Dias; Dongun Han; Sorah Yoon; Ashley Shea; Vladislav Zakharov; David Parham; Sally R Sarawar
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

Review 7.  The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages.

Authors:  J Robert Coleman
Journal:  Virol J       Date:  2007-01-15       Impact factor: 4.099

8.  Full Spectrum of LPS Activation in Alveolar Macrophages of Healthy Volunteers by Whole Transcriptomic Profiling.

Authors:  Miguel Pinilla-Vera; Zeyu Xiong; Yutong Zhao; Jing Zhao; Michael P Donahoe; Suchitra Barge; William T Horne; Jay K Kolls; Bryan J McVerry; Anastasiya Birukova; Robert M Tighe; W Michael Foster; John Hollingsworth; Anuradha Ray; Rama Mallampalli; Prabir Ray; Janet S Lee
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

Review 9.  Vaccines for preventing influenza in the elderly.

Authors:  Vittorio Demicheli; Tom Jefferson; Carlo Di Pietrantonj; Eliana Ferroni; Sarah Thorning; Roger E Thomas; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01

Review 10.  The burden of influenza in East and South-East Asia: a review of the English language literature.

Authors:  James M Simmerman; Timothy M Uyeki
Journal:  Influenza Other Respir Viruses       Date:  2008-05       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.